A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ASO / allele-specific oligonucleotide

[Related PubMed/MEDLINE]
Total Number of Papers: 199
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ASO  (>> Co-occurring Abbreviation)
Long Form:   allele-specific oligonucleotide
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 Overlapping prison/community tuberculosis outbreaks in Costa Rica revealed by alternative analysis of suboptimal material. MIRU-VNTR, PCR
2020 Measurable residual disease in the treatment of chronic lymphocytic leukemia. CLL, MRD, RQ-PCR
2019 Comprehensive Data of P53 R282 Gene Mutation with Human Papillomaviruses (HPV)-Associated Oral Squamous Cell Carcinoma (OSCC). FFPE, HPV, OSCC, PCR
2019 Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal? CLL, ddPCR, FCM, IgH, MRD, NGS, OS, PFS, RQ-PCR
2019 Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma. MM, MRD, NGS, PC, PNQ, RQ
2018 Evaluating the association of bone morphogenetic protein 4-V152A and SIX homeobox 6-H141N polymorphisms with congenital cataract and microphthalmia in Western Indian population. BMP4, CI, OR, PCR, SIX6
2018 Molecular characterization of Hb H disease in southern Thailand. HbH, mPCR, RDB
2017 Standardisation of minimal residual disease in multiple myeloma. LC, MRD, NGS
2016 Gene Polymorphisms and Serum Levels of Pro- and Anti-Inflammatory Markers in Dengue Viral Infections. CRP, IFN, IL, PCR, TNF
10  2016 LGALS3 and AXIN1 gene variants playing role in the Wnt/ beta-catenin signaling pathway are associated with mucinous component and tumor size in colorectal cancer. ELISA, PCR-RFLP
11  2016 Silencing of microRNA-138-5p promotes IL-1beta-induced cartilage degradation in human chondrocytes by targeting FOXC1: miR-138 promotes cartilage degradation. ACAN, ECM, FOCX1, GAGs, IL-1beta, miRNAs, MMP, mRNA, OA, qRT-PCR
12  2015 Hyperdiploidy associated with T315I mutation in BCR-ABL kinase domain in an accelerated phase-chronic myeloid leukemia case. AP, CML, IM, KD, Ph
13  2015 Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies. ALL, MRD, PCR
14  2015 Quantitative polymerase chain reaction analysis with allele-specific oligonucleotide primers for individual IgH VDJ regions to evaluate tumor burden in myeloma patients. MM, MRD, PCR
15  2013 A highly specific q-RT-PCR assay to address the relevance of the JAK2WT and JAK2V617F expression levels and control genes in Ph-negative myeloproliferative neoplasms. B2M, ET, GUSB, PLTs, PMF, PV
16  2013 Application of the ASLP technology to a novel platform for rapid and noise-free multiplexed SNP genotyping. ASLP, LSO, SNPs, US
17  2013 Dumbbell-shaped DNA analytes amplified by polymerase chain reaction for robust single-nucleotide polymorphism genotyping by affinity capillary electrophoresis. SNP, ssDNA
18  2012 Analysis of common mitochondrial DNA mutations by allele-specific oligonucleotide and Southern blot hybridization. LHON, mtDNA, NARP
19  2012 Kappa deleting element as an alternative molecular target for minimal residual disease assessment by real-time quantitative PCR in patients with multiple myeloma. KDE, MM, MRD, RSS
20  2011 Comparative quantitative analysis of BCR-ABL transcripts with the T315I mutant clone by polymerase chain reaction (PCR)-Invader method. CML, FOZ, PCR
21  2011 Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor. BD, ECS, RFLP
22  2011 Genotyping by alkaline dehybridization using graphically encoded particles. MM, PM
23  2011 Molecular basis of beta-thalassemia in the United Arab Emirates. ARMS, beta-TI, beta-TM, Hb, PCR, REA, UAE
24  2010 [Assessment of minimal residual disease in adult patients with B-lineage acute lymphoblastic leukemia using rearranged immunoglobulin loci detection]. B-ALL, CR, IgH, MRD, RQ-PCR
25  2009 Genotyping of mutations in the beta-globin gene using allele specific hybridization. ---
26  2008 Simultaneous detection of multiple point mutations using allele-specific oligonucleotides. TMAC
27  2008 Split hybridisation probes for electrochemical typing of single-nucleotide polymorphisms. SNPs
28  2008 Validity test study of JAK2 V617F and allele burden quantification in the diagnosis of myeloproliferative diseases. ET, HP, PCR, PNA, PV, qPCR, ROC, Se, Sp
29  2008 [Characteristics of T cell receptor beta gene rearrangements and its role in minimal residual disease detection in childhood T-cell acute lymphoblastic leukemia]. MNC, PCR, T-ALL, TCRbeta
30  2007 Design of an optimal allele-specific oligonucleotide probe for the efficient discrimination of a thermodynamically stable (G x T) mismatch. ---
31  2007 [Monitoring IgH levels in patients with B-cell malignancy by real-time quantitative PCR after hematopoietic stem cell transplantation and its significance]. CCyR, CR, HSCT
32  2006 Genotypic heterogeneity and correlation to intergenic haplotype within high HbF beta-thalassemia intermedia. BFU-e, HPFH, LCR, RFLP, RT-PCR
33  2006 High-throughput genotyping with infrared fluorescence allele specific hybridization (iFLASH): a simple, reliable and low-cost alternative. iFLASH, RFLP
34  2006 Molecular analysis of mitochondrial DNA point mutations by polymerase chain reaction. mtDNA, PCR, RFLP
35  2006 Spectrum of beta-thalassemia mutations in various regions of Punjab and Islamabad, Pakistan: establishment of prenatal diagnosis. CVS
36  2005 Comparison of the novel quantitative ARMS assay and an enriched PCR-ASO assay for K-ras mutations with conventional cytology on endobiliary brush cytology from 312 consecutive extrahepatic biliary stenoses. ARMS, EBS, PPV
37  2005 Consensus JH gene probes with conjugated 3'-minor groove binder for monitoring minimal residual disease in acute lymphoblastic leukemia. ALL, MGB, MRD, RQ-PCR
38  2005 Relationship between the regulatory region polymorphism of human tissue kallikrein gene and essential hypertension. PCR
39  2005 Screening for mitochondrial DNA heteroplasmy in children at risk for mitochondrial disease. CR
40  2005 Technology platforms for molecular diagnosis of cystic fibrosis. CF, SSCP
41  2004 A mitochondrial DNA mutation in a patient with an extensive family history of Duchenne muscular dystrophy. MELAS, mtDNA, PCR, RFLP
42  2004 Analysis of genomic CFTR DNA. DHPLC, SSCP
43  2004 Enhanced detection of deleterious mutations by TTGE analysis of mother and child's DNA side by side. mtDNA, Pro, RFLP, TTGE
44  2004 Four-color multiplex 5' nuclease assay for the simultaneous detection of the factor V Leiden and the prothrombin G20210A mutations. FVL, PT
45  2004 In multiple myeloma clonotypic CD38- /CD19+ / CD27+ memory B cells recirculate through bone marrow, peripheral blood and lymph nodes. GC, PC, PLN
46  2004 Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy. BM, DLBCL, FLgr3, HDT, IgH, OS, PBPC, PFS, qRT-PCR
47  2004 Preconceptional screening of couples for carriers of cystic fibrosis: a prospective evaluation of effects, costs and savings for different mutation detection methods. CF, DETS, DGGE, SETS
48  2004 Rapid detection of common Chinese glucose-6-phosphate dehydrogenase (G6PD) mutations by microarray-based assay. G6PD
49  2003 A single nucleotide primer extension assay to detect the APC I1307K gene variant. APC
50  2003 Analysis of cystic fibrosis transmembrane conductance regulator gene mutations in patients with congenital absence of the uterus and vagina. CAUV, CBAVD, CFTR, PCR
51  2003 Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. MRD, RQ-PCR
52  2003 Development of consensus fluorogenically labeled probes of the immunoglobulin heavy-chain gene for detecting minimal residual disease in B-cell non-Hodgkin lymphomas. B-NHL, FR3, IgH, MRD, RQ-PCR
53  2003 Heterozygosity for the Cys282Tyr mutation in the HFE gene and the risk of colorectal cancer (Netherlands). ---
54  2003 Quantitative assessment of contaminating tumor cells in autologous peripheral blood stem cells of B-cell non-Hodgkin lymphomas using immunoglobulin heavy chain gene allele-specific oligonucleotide real-time quantitative-polymerase chain reaction. IgH, MRD, NHL, PBSC, RQ-PCR
55  2003 Rapid detection of six common Mediterranean and three non-Mediterranean alpha-thalassemia point mutations by reverse dot blot analysis. RDB
56  2003 Rapid detection of the known SNPs of CYP2C9 using oligonucleotide microarray. CYP2C9, HBP, SNP
57  2003 Rapid single-base mismatch detection in genotyping for phenylketonuria. PAH, PKU
58  2003 ras oncogene mutations in diethylnitrosamine-induced hepatic tumors in medaka (Oryzias latipes), a teleost fish. DEN, RT-PCR
59  2003 Single tube multiplex PCR detection of 27 cystic fibrosis mutations and 4 polymorphisms using neonatal blood samples collected on Guthrie cards. ACMG/ACOG, CF, PCR
60  2003 Size and composition of T-cell receptor delta (TCRD) junctional sequences are not predictive of the sensitivity of clonospecific oligonucleotides designed for detection of minimal residual disease in acute lymphoblastic leukemia. ALL, MRD, TCRD
61  2002 A negative-selection strategy for depleting myeloma cells from patients' BM and/or leukapheresis blood. ---
62  2002 A novel point mutation (C571T) in the tissue-non-specific alkaline phosphatase gene in a case of adult-type hypophosphatasia. ALP, C571T, HOPS, PCR, SSCP, TNSALP
63  2002 Accuracy of genotyping for single nucleotide polymorphisms by a microarray-based single nucleotide polymorphism typing method involving hybridization of short allele-specific oligonucleotides. SNPs
64  2002 Familial dysautonomia: detection of the IKBKAP IVS20(+6T --> C) and R696P mutations and frequencies among Ashkenazi Jews. AJ, FD, IKBKAP
65  2002 Molecular analysis of beta-thalassaemia patients in a high incidence area of southern Italy. PCR
66  2002 Quantitative assessment of minimal residual disease in childhood lymphoid malignancies using an allele-specific oligonucleotide real-time quantitative polymerase chain reaction. MRD, RQ-PCR
67  2002 Rapid detection of the hypertension-associated A1166C polymorphism of the angiotensin II type 1 receptor (AGTR1). AGTR1
68  2002 Rapid detection of the sacsin mutations causing autosomal recessive spastic ataxia of Charlevoix-Saguenay. ---
69  2002 Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment. ALL, CML, FISH, RT-PCR-RFLP
70  2002 [Analysis of HLA-DR in Mexican patients with pemphigus]. ---
71  2002 [Linkage analysis of the G6PD gene mutations and its Nla III polymorphic site]. DGGE, G6PD
72  2001 Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL. ALL, FC, MRD
73  2001 Immunomagnetic enrichment of CD138 positive cells from weakly infiltrated myeloma patients samples enables the determination of the tumor clone specific IgH rearrangement. BM, LA, PB, PCR
74  2001 Linked linear amplification: a new method for the amplification of DNA. LLA
75  2001 Mutational analysis within the 3' region of the PKD1 gene in Japanese families. ADPKD
76  2001 Nonradioactive detection of the common Connexin 26 167delT and 35delG mutations and frequencies among Ashkenazi Jews. Cx26, GJB2, NSRD
77  2000 Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. ALL, Ct, Ig, IgH, MRD, RQ-PCR, TCR
78  2000 Comparison study for identifying promoter allelic polymorphism in interleukin 10 and tumor necrosis factor alpha genes. IL, PCR, TNF
79  2000 Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study. Belgium-Dutch Hematology-Oncology Group. PCR
80  2000 DNA damage promotes mistyping in the allele specific oligonucleotide probing analysis of forensic samples. HLA, PCR
81  2000 Evaluation of the kinetics of the bone marrow tumor load in the course of sequential high-dose therapy assessed by quantitative PCR as a predictive parameter in patients with multiple myeloma. BM, HDT, MM, PB, PBSCT
82  2000 Identification of a premature stop codon in the melanocyte-stimulating hormone receptor gene (MC1R) in Labrador and Golden retrievers with yellow coat colour. ---
83  2000 Monitoring hybridization during polymerase chain reaction. DGGE, DHPLC, PCR, SSCP, TGGE
84  2000 Quantitation of minimal residual disease in multiple myeloma using an allele-specific real-time PCR assay. BM, CDR3, IgH, MM, MRD, PBSC
85  2000 Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology. ALL, MRD, TCR
86  1999 A multiplex ARMS test for 10 cystic fibrosis (CF) mutations: evaluation in a prenatal CF screening program. ARMS, CF
87  1999 Ashkenazi Jewish population frequency of the Bloom syndrome gene 2281 delta 6ins7 mutation. ---
88  1999 CDKN2A variants in a population-based sample of Queensland families with melanoma. CMM, nts
89  1999 Circulating clonal cells in multiple myeloma do not express CD34 mRNA, as measured by single-cell and real-time RT-PCR assays. MM, PB
90  1999 Clinical utility of immunoglobulin heavy chain gene rearrangement identification for tumour cell detection in multiple myeloma. CR, IgH, MRD
91  1999 Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. ACE, AGT, Ang II
92  1999 Molecular diagnosis of hypophosphatasia with severe periodontitis. HOPS, PCR, SSCP, T1155C, TNSALP
93  1999 Novel mutations associated with carnitine palmitoyltransferase II deficiency. CPT II
94  1999 Prenatal diagnosis of beta-thalassaemia by reverse dot-blot hybridization. PCR
95  1999 Rapid detection of CYP1A1, CYP2D6, and NAT variants by multiplex polymerase chain reaction and allele-specific oligonucleotide assay. ---
96  1998 A rationale for positive selection of peripheral blood stem cells in multiple myeloma: highly purified CD34+ cell fractions of leukapheresis products do not contain malignant cells. LP, MM
97  1998 Evaluation of the BeTha gene 1 kit for the qualitative detection of the eight most common Mediterranean beta-thalassemia mutations. ELISA, PCR
98  1998 First and second apheresis in patients with multiple myeloma: no differences in tumor load and hematopoietic stem cell yield. HD, LP, LP5, MM, PBSC
99  1998 Human alpha-L-iduronidase (IDUA) gene: apparent recombination in intron 2 by haplotype analysis in a Taiwanese population. IDUA, RFLP, VNTR
100  1998 Human alpha-L-iduronidase (IDUA) gene: correlation of polymorphic DNA haplotype and IDUA activity in Chinese population. IDUA, RFLP